Investing in health [Elektronisk resurs] The social and economic benefits of health care innovation / Kent Summers, Alan L. Sorkin; Edited by Irina Farquhar.

• The frontiers of genetics and the transformation of medicine and business, R. Field-- outpatient prescription drug prices and insurance coverage - an analysis by therapeutic drug class and user characteristics from the 1996 medical expenditure panel survey, G. Edward Miller, J. Moeller-- pharmaceutical spending and health outcomes - a state level analysis, P.Y. Cremieux, et al.-- too many drugs?, A. Wertheimer, R. Levy, T. O'Connor-- factors affecting health services utilization in the medicare population - would providing prescription drug coverage to medicare recipients affect their use of health care resources, M.A. Cifaldi-- estimating economic cost of HIV/AIDS-related diseases, I. Farquhar, et al-- estimating the social and economic benefits of pharmaceutical innovation - modelling clinical trial results in HIV-disease, K. Simpson, et al-- concomitant illness in patients with diabetes - morality, morbidity, benefits of newer treatments, and individual and societal costs, I. Farquhar, et al-- factors influencing patient willingness to pay for diabetes - disease state management programmes, J. Barner-- assessment of the relationship between quality of life and willingness to pay for in vitro fertilization in patients undergoing treatment for infertility, T. Stavinoha, J. Barner-- impact of diabetes on human capital and quality of life, K. Summers, R. Hayes-- energy and improved workplace productivity in depression, R. Swindle, K. Kroenke, L. Braun-- can mental health treatment be effectively delivered in primary care? a primer for employee benefit design, decision makers, and an outcome research example, R. Swindle, et al-- the interaction of depression and smoking on workplace productivity, M. Halpern, Z. Khan, A. Rentz-- cost-effectiveness in the prevention of suicide - a population approach, L. von Knorring, et al-- payment effects on resource utilization and outcomes for patients with congestive heart failure, E. Kroch, et al.

• Presents studies contributing to the enhancement of the outcomes research paradigm by incorporating economic and social interactions within the health care delivery, clinical decision-making and outcomes systems. This book addresses benefits and cost of advancements in genetic technologies. -- Public health has, for many years, been concerned with efforts to increase the efficiency of health care delivery, to measure changes in health care resource utilization and associated costs, and to link these changes to different types of interventions. These efforts, as well as collaboration between biopharmaceutical organizations, producers of medical devices, and managed care and public health organizations, have been enhanced by the opportunities created within the fast growing field of outcomes research. This volume presents studies contributing to the enhancement of the outcomes research paradigm by incorporating economic and social interactions within the health care delivery, clinical decision-making and outcomes systems. A multidisciplinary team of scientists in the fields of outcomes research, pharmacoeconomics, public health, health services research, and health economics address such complex problems as: benefits and cost of advancements in genetic technologies; methodologies for constructing health care utilization and cost estimates; and the effect of insurance type on resource utilization and health outcomes. Other studies consider both the types of drugs purchased and the prices paid, pharmaceutical spending and health outcomes, incremental advantages of newer treatments, willingness to pay measurements, disease-specific impacts on human capital and quality of life, and modeling clinical trial results. One of the most important findings in this book is the description of the role of low energy in the symptomatology of depression and its strong relationship with absenteeism, work productivity and social functioning. Another paper documents the disease-specific mortality, case-fatality and annual health care utilization in diabetics and establishes the association of respiratory conditions with elevated mortality among diabetics. The work contains other papers which provide significant results in cardiovascular, infectious, central nervous system disease areas as well as in quality of life and health outcomes measurements. 

Ämnesord

Health and Fitness.  (eflch)

Hälsorisker  (albt)

Hälsoundersökning  (albt)

Hjärt- och kärlsjukdomar  (albt)

Järn- och stålindustri  (albt)

Andningsorganens sjukdomar  (albt)

Klassifikation

HEA (ämneskategori)

362.1 (DDC)

Vp (kssb/8 (machine generated))